- Preliminary Analysis confirms the presence of TGR-63 in brain tissue and shows no adverse effects. - POTOMAC, Md.--(BUSINESS WIRE)-- IGC Pharma, Inc. (NYSE American: IGC) (“IGC” or the “Company”) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results